ASKA Pharmaceutical Holdings Co.,Ltd. (TYO:4886)

TYO:4886 Revenue

ASKA Pharmaceutical Holdings had revenue of 15.93B JPY in the quarter ending September 30, 2025, a decrease of -0.54%. This brings the company's revenue in the last twelve months to 67.02B, up 5.44% year-over-year. In the fiscal year ending March 31, 2025, ASKA Pharmaceutical Holdings had annual revenue of 64.14B with 2.06% growth.

• Revenue (ttm): 67.02B
• Revenue Growth: +5.44%
• P/S Ratio: 0.89
• Revenue / Employee: 41.07M
• Employees: 1,632
• Market Cap: 59.97B

Revenue History

Fiscal Year End	Revenue	Change	Growth
Mar 31, 2025	64.14B	1.30B	2.06%
Mar 31, 2024	62.84B	2.38B	3.94%
Mar 31, 2023	60.46B	3.85B	6.81%
Mar 31, 2022	56.61B	1.43B	2.58%
Mar 31, 2021	55.18B	2.64B	5.02%